CircaGene

CircaGene
CircaGene provides a personal DNA test to get to know your health risks and plan your future with total privacy so that you can take a proactive approach to your health. CircaGene offers DNA analysis for individuals and population with a genetic predisposition to diseases with its unique in the world patent covering DNA security, which allows for genomic analysis whilst protecting individual data. The company has the World's first End-to-end Encryption incognito of DNA, guaranteeing that only the user can have access to their results and protecting their Genetic Privacy by innovative methods of personalised analysis. The company has customers and is selling in the market though web and app stores. CircaGene is a Portfolio Select from Founders Institute for Silicon Valley, carries no debt, and keeps growing every day.
Business Highlights
lock
Video
lock
Investment Deck
lock
Team
lock

03Other opportunities

SFC Angel Fund

SFC Angel Fund

Invest in an award-winning fund focused on disruptive businesses in the UK.
Fund Size £20m SEIS/EIS
SFC Angel Fund SEIS

SFC Angel Fund SEIS

Invest in the innovations of tomorrow.
Fund Size £20M SEIS
SFC Angel Fund EIS

SFC Angel Fund EIS

Invest in the Top 10% performers of SFC’s existing portfolio.
Fund Size £10M EIS
Algocyte Algocyte

Algocyte

Helping doctors monitor patient's health whenever necessary, wherever they are.
Raising TBD SEIS/EIS